AHN-GOOK PHARMACEUTICAL
Ahn-Gook Pharmaceutical is a pharmaceutical manufacturing company.
AHN-GOOK PHARMACEUTICAL
Industry:
Biotechnology Manufacturing Pharmaceutical
Founded:
1959-02-12
Address:
Yongdungpo, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.ahn-gook.com
Total Employee:
251+
Status:
Active
Technology used in webpage:
Apache PHP Java EE IIS 8 CentOS Apache 2.2 South Korean Server Location
Similar Organizations
Bharat Parenterals
Bharat Parenterals is a pharmaceutical manufacturing company.
Dong Nai Pharmaceutical
Dong Nai Pharmaceutical is a Vietnam-based pharmaceutical manufacturing company.
Enlie Pharmaceutical
Enlie Pharmaceutical is a Vietnam-based pharmaceutical manufacturing company.
Hovid Berhad
Hovid has years of invaluable pharmaย industry experience, and has grown to be among the pharmaceutical manufacturers in Malaysia.
Megapharm
Megapharm is a pharmaceutical and biotech marketing company.
Officina Profumo Farmaceutica di Santa Maria Novella
Santa Maria Novella's Officina Profumo Farmaceutica offers exquisite perfumes and skincare items produced with medical plants.
Saudi Bio
Saudi Bio is an insulin manufacturing company.
Upjohn Pharmaceuticals
Upjohn Pharmaceuticals is a pharmaceutical manufacturing company.
Yichang HEC Changjiang Pharmaceutical Co. Ltd.
Yichang HEC Changjiang Pharmaceutical Co. Ltd is a PRC pharmaceutical manufacturing company
Zenkom
Zenkom is a drug manufacturing and sales company.
Official Site Inspections
http://www.ahn-gook.com Semrush global rank: 4.01 M Semrush visits lastest month: 2.69 K
- Host name: mail.ahn-gook.com
- IP address: 210.126.248.226
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Ahn-Gook Pharmaceutical"
ahn-gook - Pharmaceutical Export Promotion Council
Ahn-Gook develops. manufactures and sells OTC (overthe counter) drugs and prescription pharmaceuticals since 1959. Ahn-Gook's strength in sales & Marketing lies in Respiratory & Gl โฆSee details»
(์ฃผ)์๊ตญ์ฝํ :: AHNGOOK
Ahn-gook Pharm has endeavored to develop and supply excellent medicines for public health for the past 60 years with a mission of โpromoting human health and happiness through โฆSee details»
Ahn-Gook Pharmaceutical - Crunchbase Company Profile & Funding
Organization. Ahn-Gook Pharmaceutical . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Ahn-Gook Pharmaceutical is a โฆSee details»
AG-1604 - Drug Targets, Indications, Patents - Synapse - Patsnap
AG-1604: a Nicotinic receptors agonists Drug, Initially developed by AHN-GOOK PHARMACEUTICAL Co., Ltd., Now, its global highest R&D status is NDA/BLA, Mechanism: โฆSee details»
Ahn-Gook Pharmaceutical Co. Ltd - PharmaBoardroom
Feb 25, 2015 Ahn-Gook has set a new vision to realize โnew world-class medicine and global marketing by 2020.โ In the 21 st century, only companies with core technology and key โฆSee details»
Ahn-Gook Pharmaceutical Co Ltd - Company Profile and News
Ahn-Gook Pharmaceutical Co., Ltd. develops, manufactures, and markets a broad range of pharmaceuticals including a digestive agent and an eye nutrient. The Company also produces โฆSee details»
Organization | Ahn-Gook Pharmaceuticals Co.,Ltd
Organization Overview. First Clinical Trial. 2006 NCT00380315. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Ahn-Gook Pharmaceuticals Co.,Ltd Active โฆSee details»
Ahngook Pharm Company Profile 2024: Stock Performance
Ahn-Gook Pharmaceutical Co Ltd manufactures and markets medicines. The company is famous for medicine for ophthalmology. The company also engages in various prescription medicines. โฆSee details»
AG-NCA805 - Drug Targets, Indications, Patents - Synapse - Patsnap
AG-NCA805, Initially developed by AHN-GOOK PHARMACEUTICAL Co., Ltd., Now, its global highest R&D status is Pending, Therapeutic Areas: Immune System Diseases,Respiratory โฆSee details»
Ahn-Gook Pharmaceutical Company Description - Stock Analysis
6 days ago Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The โฆSee details»
About the Manufacturers - Delex Pharma
Ahn-gook Pharmaceutical Co., Ltd. has exhibited outstanding development and supply of quality medicines for the last forty-five (45) years. It has achieved KOSDAQ enlistment, a trading โฆSee details»
AG-B1512 - Drug Targets, Indications, Patents - Synapse
Accelerate Strategic R&D decision making with Synapse, PatSnapโs AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.See details»
001540.KQ - | Stock Price & Latest News | Reuters
Nov 30, 2024 AHN-GOOK PHARMACEUTICAL Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyโs products include respiratory agents, โฆSee details»
AG 1601 - AdisInsight - Springer
Nov 19, 2021 AG 1601 is an incrementally modified drug being developed by Ahn Gook Pharmaceutical for the treatment of immunological disorders. Clinical development is AG 1601 โฆSee details»
UAI 101 - AdisInsight - Springer
UAI 101 is a new chemical entity developed by Ahn Gook Pharmaceutical for the treatment of metabolic disorders, including diabetes mellitus. Preclinical UAI 101 Next ... If your โฆSee details»
AG-1601 - Drug Targets, Indications, Patents - Synapse
AG-1601, Initially developed by AHN-GOOK PHARMACEUTICAL Co., Ltd., Now, its global highest R&D status is Pending, Therapeutic Areas: Skin and Musculoskeletal Diseases. ...See details»
AG-1904 - Drug Targets, Indications, Patents - Synapse
AG-1904, Initially developed by AHN-GOOK PHARMACEUTICAL Co., Ltd., Now, its global highest R&D status is Pending, Therapeutic Areas: Infectious Diseases,Respiratory Diseases.See details»
AG-1801 - Drug Targets, Indications, Patents - Synapse
AG-1801, Initially developed by AHN-GOOK PHARMACEUTICAL Co., Ltd., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Respiratory Diseases.See details»
AG 1501 - AdisInsight
Ahn Gook Pharmaceutical is developing AG 1501, an incrementally modified formulation of an undisclosed drug, for the treatment of metabolic disorders. The AG 1501 Next ... If your โฆSee details»
AGB P1 - AdisInsight - Springer
Sep 28, 2021 Ahn Gook Pharmaceutical is developing AGB P1, an incrementally modified formulation of an undisclosed drug, for the treatment of musculoskeletal disorders. The ... If โฆSee details»